K E Dyker
Overview
Explore the profile of K E Dyker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
91
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waldram R, Taylor A, Whittam S, Iyizoba-Ebozue Z, Murray L, Frood R, et al.
Clin Oncol (R Coll Radiol)
. 2019 Nov;
32(4):228-237.
PMID: 31668378
Aims: To evaluate patterns of locoregional recurrence following adjuvant (chemo)radiotherapy for oral cavity squamous cell carcinomas. Materials And Methods: One hundred and one patients who received adjuvant radiotherapy ± chemotherapy...
2.
Ramasamy S, Murray L, Cardale K, Dyker K, Murray P, Sen M, et al.
Clin Oncol (R Coll Radiol)
. 2019 Mar;
31(6):344-351.
PMID: 30890299
Aims: To assess the impact of weekly scheduled peer review of head and neck contours for definitive and adjuvant radiotherapy cases based on rates of recommended changes. Materials And Methods:...
3.
Arunsingh M, Vaidyanathan S, Dyker K, Sen M, Scarsbrook A, Prestwich R
Clin Oncol (R Coll Radiol)
. 2018 Dec;
31(4):212-218.
PMID: 30553580
Aim: There are few data to inform on the use of response assessment 2-[fluorine-18]-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography-computed tomography (PET-CT) following radical radiotherapy without chemotherapy for head and neck squamous...
4.
Metcalfe E, Aspin L, Speight R, Ermis E, Ramasamy S, Cardale K, et al.
Clin Oncol (R Coll Radiol)
. 2016 Oct;
29(1):51-59.
PMID: 27712917
Aims: To determine outcomes after adjuvant radiotherapy for squamous cell carcinoma of the oral cavity and to correlate locoregional recurrence patterns with radiotherapy target volumes. Materials And Methods: All patients...
5.
Bayman E, Prestwich R, Speight R, Aspin L, Garratt L, Wilson S, et al.
Clin Oncol (R Coll Radiol)
. 2014 Jun;
26(10):636-42.
PMID: 24928558
Aims: To determine the pattern of disease recurrence in non-nasopharyngeal head and neck squamous cell carcinoma (HNSCC) patients treated with radical intensity-modulated radiotherapy (IMRT) with or without chemotherapy, and to...
6.
Prestwich R, Teo M, Gilbert A, Williams G, Dyker K, Sen M
Clin Oncol (R Coll Radiol)
. 2013 Nov;
26(2):103-9.
PMID: 24246275
Aims: Two contrasting approaches of a prophylactic gastrostomy or a nasogastric tube as needed are widely used to support patients receiving chemoradiotherapy for head and neck cancer. The influence of...
7.
Teo M, Karakaya E, Young C, Dyker K, Coyle C, Sen M, et al.
Clin Oncol (R Coll Radiol)
. 2013 Aug;
25(11):647-53.
PMID: 23948462
Aims: The role of induction chemotherapy (ICT) for head and neck squamous cell carcinoma (HNSCC) is controversial. The aim of the study was to assess the benefit of ICT with...
8.
Prestwich R, Sykes J, Carey B, Sen M, Dyker K, Scarsbrook A
Clin Oncol (R Coll Radiol)
. 2012 May;
24(8):577-89.
PMID: 22592142
Defining the target for head and neck radiotherapy is a critical issue with the introduction of steep dose gradients associated with intensity-modulated radiotherapy. Tumour delineation inaccuracies are a major source...
9.
Kancherla K, Oksuz D, Prestwich R, Fosker C, Dyker K, Coyle C, et al.
Clin Oncol (R Coll Radiol)
. 2010 Oct;
23(2):141-8.
PMID: 20934860
Aims: A significant proportion of patients with head and neck squamous cell carcinoma are unsuitable for radical treatment due to factors including tumour stage, performance status and co-morbidity. Palliative radiotherapy...